Composite primary neuronal high-content screening assay for Huntington's disease incorporating non-cell-autonomous interactions.

Published

Journal Article

Huntington's disease (HD) is a fatal neurodegenerative disease characterized by progressive cognitive, behavioral, and motor deficits and caused by expansion of a polyglutamine repeat in the Huntingtin protein (Htt). Despite its monogenic nature, HD pathogenesis includes obligatory non-cell-autonomous pathways involving both the cortex and the striatum, and therefore effective recapitulation of relevant HD disease pathways in cell lines and primary neuronal monocultures is intrinsically limited. To address this, the authors developed an automated high-content imaging screen in high-density primary cultures of cortical and striatal neurons together with supporting glial cells. Cortical and striatal neurons are transfected separately with different fluorescent protein markers such that image-based high-content analysis can be used to assay these neuronal populations separately but still supporting their intercellular interactions, including abundant synaptic interconnectivity. This assay was reduced to practice using transfection of a mutant N-terminal Htt domain and validated via a screen of ~400 selected small molecules. Both expected as well as novel candidate targets for HD emerged from this screen; of particular interest were target classes with close relative proximity to clinical testing. These findings suggest that composite primary cultures incorporating increased levels of biological complexity can be used for high-content imaging and "high-context" screening to represent molecular targets that otherwise may be operant only in the complex tissue environment found in vivo during disease pathogenesis.

Full Text

Cited Authors

  • Kaltenbach, LS; Bolton, MM; Shah, B; Kanju, PM; Lewis, GM; Turmel, GJ; Whaley, JC; Trask, OJ; Lo, DC

Published Date

  • August 2010

Published In

Volume / Issue

  • 15 / 7

Start / End Page

  • 806 - 819

PubMed ID

  • 20581077

Pubmed Central ID

  • 20581077

Electronic International Standard Serial Number (EISSN)

  • 1552-454X

International Standard Serial Number (ISSN)

  • 1087-0571

Digital Object Identifier (DOI)

  • 10.1177/1087057110373392

Language

  • eng